Based on new knowledge from the Nationwide Well being and Diet Examination Survey (NHANES), the weight problems charge in the US dropped by roughly two share factors between 2020 and 2023.
There isn’t any direct proof that hyperlinks the declining charges with the rising recognition of GLP-1 prescription weight reduction medication resembling Wegovy, Ozempic and Mounjaro. Nevertheless, the Monetary Instances mentioned it’s “extremely doubtless” medication performed a serious position.
Based on the Mayo Clinic, one in eight People has used prescription weight reduction medication, which may end up in a complete physique weight lack of 3-12 p.c greater than way of life adjustments alone. Faculty graduates, who’re extra rising extra fascinated with weight reduction medication, are seeing the steepest decline in weight problems charges. The utilization of those medicines took off in 2021, proper within the interval when the drop was confirmed, as reported by The Impartial.
Jim Roza, chief scientific officer at Layn Pure Substances (China/Irvine, CA), mentioned GLP-1 agonists are being promoted as an answer to weight problems, however because of excessive prices, unintended effects, availability issues and long-term dedication, they don’t seem to be the one resolution in addressing the weight problems epidemic.
“Research have proven that consuming meals excessive in protein, wholesome fat, and fiber can stimulate the discharge of this hormone thereby slowing digestion and selling satiety each of that are key elements in weight administration,” Roza mentioned. “Customers must also be cautious of claims made for the polyphenol, berberine, as a pure different to those medication. Whereas some analysis has proven that berberine could also be useful in selling wholesome blood sugar and supporting a wholesome inflammatory response, there may be not sufficient proof to declare it as being bioequivalent.”
